Pharmaceutical Drug Discovery & Development
Target identification, lead optimization, medicinal chemistry, high-throughput screening, in silico drug design, and translational strategies from hit discovery to IND application.
Speaker profile
Conference homeSessions
A curated scientific program featuring parallel sessions across pharmaceutical drug discovery, clinical trials, drug formulation, biopharmaceuticals, pharmacovigilance, GMP manufacturing, and precision medicine. The agenda includes keynote lectures, expert scientific discussions, poster presentations, and interactive pharmaceutical research workshops.
The conference will be organized around thematic tracks, reflecting the main focus areas of pharmaceutical sciences and drug development. These tracks encourage participants to explore their topic in depth, while answer interdisciplinary questions from beyond their domain.
Target identification, lead optimization, medicinal chemistry, high-throughput screening, in silico drug design, and translational strategies from hit discovery to IND application.
Phase I–III trial design, regulatory submissions, FDA/EMA/ICH guidelines, clinical data management, GCP compliance, and adaptive trial methodologies.
Controlled release, nanoparticle delivery, transdermal systems, oral bioavailability, injectable formulations, and advanced drug delivery technologies.
ADMET profiling, drug-drug interactions, bioequivalence, population PK modeling, metabolite identification, and PK/PD relationship studies.
Monoclonal antibodies, gene therapy, CAR-T cell therapy, mRNA therapeutics, biosimilars, protein engineering, and next-generation biologic drug development.
Adverse event reporting, signal detection, risk management, post-marketing surveillance, pharmacoepidemiology, and global drug safety standards.
Good Manufacturing Practice (GMP), quality by design, process analytical technology, supply chain integrity, contamination control, and pharmaceutical quality systems.
Genomic biomarkers, companion diagnostics, pharmacogenomics, stratified medicine, oncology precision therapy, and individualized dosing strategies.
The list of topics covers the current and future research times in pharmaceutical sciences, drug discovery, and clinical research: from laboratory to patient.
Program sessions include presentations, poster sessions, and workshops, which together foster knowledge exchange, discussion, and collaboration.
Thought leaders in pharmaceutical sciences and drug development present transformative insights reshaping drug discovery, regulatory strategy, and precision medicine globally.
Peer-reviewed pharmaceutical research delivered in focused scientific tracks and specialty clinical and regulatory sessions.
Dedicated viewing periods with pharmaceutical researchers available for interactive dialogue and drug development research networking.
Expert exchanges on regulatory strategy, clinical trial design, pharmacovigilance policy, and evidence-based approaches to drug safety and efficacy.
Hands-on sessions covering formulation development techniques, regulatory dossier preparation, pharmacokinetic modeling, GMP compliance audits, and bioanalytical method validation.
Mentored presentations by early-career pharmaceutical scientists, clinical pharmacologists, regulatory affairs professionals, and biotech researchers exploring innovative directions in drug development.
Visit PBC-2027 in San Diego, California and connect with leading pharmaceutical scientists, drug developers, clinical researchers, regulatory specialists, and biotech innovators advancing the science and practice of modern medicine worldwide.